BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-688@pharmaconomics
DTSTAMP:20260707T052558Z
DTSTART;VALUE=DATE:20250430
DTEND;VALUE=DATE:20250501
SUMMARY:ABEO Approval — ZEVASKYN (estimated date)
DESCRIPTION:A final FDA approval decision on ZEVASKYN for recessive dystrophic epidermolysis bullosa (RDEB) is expected ~ Apr 30\, 2025.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/318306/000149315226022610/ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/688
URL:https://pharmaconomics.com/e/688
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ABEO catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR